Report Detail
Global (United States, European Union and China) Pulmonary Drug Delivery Devices/Systems Market Research Report 2019-2025
- RnM3622684 |
- 29 July, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Other
Pulmonary Drug Delivery Devices/Systems include metered dose inhalers,dry powder inhalers,nebulizers and accessories.
North America dominates the dominant drug delivery devices/systems market position. Major local pharmaceutical and medical device manufacturers, advanced medical infrastructure, population ageing, high disposable income and lifestyle changes are all factors driving the overall growth of the North American pharmaceutical drug delivery devices/systems market.
In 2019, the market size of Pulmonary Drug Delivery Devices/Systems is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Pulmonary Drug Delivery Devices/Systems.
This report studies the global market size of Pulmonary Drug Delivery Devices/Systems, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Pulmonary Drug Delivery Devices/Systems production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Hovione
3M Health Care
Bespak
BeyonDevices
GlaxoSmithKline
H&T Presspart
PARI Respiratory Equipment
Philips Respironics
SHL Group
Market Segment by Product Type
Metered Dose Inhalers
Dry Powder Inhalers
Nebulizers
Accessories
Market Segment by Application
Hospitals and Clinics
Homecare
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Pulmonary Drug Delivery Devices/Systems status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Pulmonary Drug Delivery Devices/Systems manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Pulmonary Drug Delivery Devices/Systems are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Research Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Pulmonary Drug Delivery Devices/Systems Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Metered Dose Inhalers
- 1.3.3 Dry Powder Inhalers
- 1.3.4 Nebulizers
- 1.3.5 Accessories
- 1.4 Market Segment by Application
- 1.4.1 Global Pulmonary Drug Delivery Devices/Systems Market Share by Application (2019-2025)
- 1.4.2 Hospitals and Clinics
- 1.4.3 Homecare
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Production and Capacity Analysis
- 2.1.1 Global Pulmonary Drug Delivery Devices/Systems Production Value 2014-2025
- 2.1.2 Global Pulmonary Drug Delivery Devices/Systems Production 2014-2025
- 2.1.3 Global Pulmonary Drug Delivery Devices/Systems Capacity 2014-2025
- 2.1.4 Global Pulmonary Drug Delivery Devices/Systems Marketing Pricing and Trends
- 2.2 Key Producers Growth Rate (CAGR) 2019-2025
- 2.2.1 Global Pulmonary Drug Delivery Devices/Systems Market Size CAGR of Key Regions
- 2.2.2 Global Pulmonary Drug Delivery Devices/Systems Market Share of Key Regions
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Capacity and Production by Manufacturers
- 3.1.1 Global Pulmonary Drug Delivery Devices/Systems Capacity by Manufacturers
- 3.1.2 Global Pulmonary Drug Delivery Devices/Systems Production by Manufacturers
- 3.2 Revenue by Manufacturers
- 3.2.1 Pulmonary Drug Delivery Devices/Systems Revenue by Manufacturers (2014-2019)
- 3.2.2 Pulmonary Drug Delivery Devices/Systems Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Pulmonary Drug Delivery Devices/Systems Market Concentration Ratio (CR5 and HHI)
- 3.3 Pulmonary Drug Delivery Devices/Systems Price by Manufacturers
- 3.4 Key Manufacturers Pulmonary Drug Delivery Devices/Systems Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Pulmonary Drug Delivery Devices/Systems Market
- 3.6 Key Manufacturers Pulmonary Drug Delivery Devices/Systems Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Production and Production Value for Each Type
- 4.1.1 Metered Dose Inhalers Production and Production Value (2014-2019)
- 4.1.2 Dry Powder Inhalers Production and Production Value (2014-2019)
- 4.1.3 Nebulizers Production and Production Value (2014-2019)
- 4.1.4 Accessories Production and Production Value (2014-2019)
- 4.2 Global Pulmonary Drug Delivery Devices/Systems Production Market Share by Type
- 4.3 Global Pulmonary Drug Delivery Devices/Systems Production Value Market Share by Type
- 4.4 Pulmonary Drug Delivery Devices/Systems Ex-factory Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Pulmonary Drug Delivery Devices/Systems Consumption by Application
6 Production by Regions
- 6.1 Global Pulmonary Drug Delivery Devices/Systems Production (History Data) by Regions 2014-2019
- 6.2 Global Pulmonary Drug Delivery Devices/Systems Production Value (History Data) by Regions
- 6.3 United States
- 6.3.1 United States Pulmonary Drug Delivery Devices/Systems Production Growth Rate 2014-2019
- 6.3.2 United States Pulmonary Drug Delivery Devices/Systems Production Value Growth Rate 2014-2019
- 6.3.3 Key Players in United States
- 6.3.4 United States Pulmonary Drug Delivery Devices/Systems Import & Export
- 6.4 European Union
- 6.4.1 European Union Pulmonary Drug Delivery Devices/Systems Production Growth Rate 2014-2019
- 6.4.2 European Union Pulmonary Drug Delivery Devices/Systems Production Value Growth Rate 2014-2019
- 6.4.3 Key Players in European Union
- 6.4.4 European Union Pulmonary Drug Delivery Devices/Systems Import & Export
- 6.5 China
- 6.5.1 China Pulmonary Drug Delivery Devices/Systems Production Growth Rate 2014-2019
- 6.5.2 China Pulmonary Drug Delivery Devices/Systems Production Value Growth Rate 2014-2019
- 6.5.3 Key Players in China
- 6.5.4 China Pulmonary Drug Delivery Devices/Systems Import & Export
- 6.6 Rest of World
- 6.6.1 Japan
- 6.6.2 Korea
- 6.6.3 India
- 6.6.4 Southeast Asia
7 Pulmonary Drug Delivery Devices/Systems Consumption by Regions
- 7.1 Global Pulmonary Drug Delivery Devices/Systems Consumption (History Data) by Regions
- 7.2 United States
- 7.2.1 United States Pulmonary Drug Delivery Devices/Systems Consumption by Type
- 7.2.2 United States Pulmonary Drug Delivery Devices/Systems Consumption by Application
- 7.3 European Union
- 7.3.1 European Union Pulmonary Drug Delivery Devices/Systems Consumption by Type
- 7.3.2 European Union Pulmonary Drug Delivery Devices/Systems Consumption by Application
- 7.4 China
- 7.4.1 China Pulmonary Drug Delivery Devices/Systems Consumption by Type
- 7.4.2 China Pulmonary Drug Delivery Devices/Systems Consumption by Application
- 7.5 Rest of World
- 7.5.1 Rest of World Pulmonary Drug Delivery Devices/Systems Consumption by Type
- 7.5.2 Rest of World Pulmonary Drug Delivery Devices/Systems Consumption by Application
- 7.5.1 Japan
- 7.5.2 Korea
- 7.5.3 India
- 7.5.4 Southeast Asia
8 Company Profiles
- 8.1 Hovione
- 8.1.1 Hovione Company Details
- 8.1.2 Company Description and Business Overview
- 8.1.3 Production and Revenue of Pulmonary Drug Delivery Devices/Systems
- 8.1.4 Pulmonary Drug Delivery Devices/Systems Product Introduction
- 8.1.5 Hovione Recent Development
- 8.2 3M Health Care
- 8.2.1 3M Health Care Company Details
- 8.2.2 Company Description and Business Overview
- 8.2.3 Production and Revenue of Pulmonary Drug Delivery Devices/Systems
- 8.2.4 Pulmonary Drug Delivery Devices/Systems Product Introduction
- 8.2.5 3M Health Care Recent Development
- 8.3 Bespak
- 8.3.1 Bespak Company Details
- 8.3.2 Company Description and Business Overview
- 8.3.3 Production and Revenue of Pulmonary Drug Delivery Devices/Systems
- 8.3.4 Pulmonary Drug Delivery Devices/Systems Product Introduction
- 8.3.5 Bespak Recent Development
- 8.4 BeyonDevices
- 8.4.1 BeyonDevices Company Details
- 8.4.2 Company Description and Business Overview
- 8.4.3 Production and Revenue of Pulmonary Drug Delivery Devices/Systems
- 8.4.4 Pulmonary Drug Delivery Devices/Systems Product Introduction
- 8.4.5 BeyonDevices Recent Development
- 8.5 GlaxoSmithKline
- 8.5.1 GlaxoSmithKline Company Details
- 8.5.2 Company Description and Business Overview
- 8.5.3 Production and Revenue of Pulmonary Drug Delivery Devices/Systems
- 8.5.4 Pulmonary Drug Delivery Devices/Systems Product Introduction
- 8.5.5 GlaxoSmithKline Recent Development
- 8.6 H&T Presspart
- 8.6.1 H&T Presspart Company Details
- 8.6.2 Company Description and Business Overview
- 8.6.3 Production and Revenue of Pulmonary Drug Delivery Devices/Systems
- 8.6.4 Pulmonary Drug Delivery Devices/Systems Product Introduction
- 8.6.5 H&T Presspart Recent Development
- 8.7 PARI Respiratory Equipment
- 8.7.1 PARI Respiratory Equipment Company Details
- 8.7.2 Company Description and Business Overview
- 8.7.3 Production and Revenue of Pulmonary Drug Delivery Devices/Systems
- 8.7.4 Pulmonary Drug Delivery Devices/Systems Product Introduction
- 8.7.5 PARI Respiratory Equipment Recent Development
- 8.8 Philips Respironics
- 8.8.1 Philips Respironics Company Details
- 8.8.2 Company Description and Business Overview
- 8.8.3 Production and Revenue of Pulmonary Drug Delivery Devices/Systems
- 8.8.4 Pulmonary Drug Delivery Devices/Systems Product Introduction
- 8.8.5 Philips Respironics Recent Development
- 8.9 SHL Group
- 8.9.1 SHL Group Company Details
- 8.9.2 Company Description and Business Overview
- 8.9.3 Production and Revenue of Pulmonary Drug Delivery Devices/Systems
- 8.9.4 Pulmonary Drug Delivery Devices/Systems Product Introduction
- 8.9.5 SHL Group Recent Development
9 Market Forecast
- 9.1 Global Market Size Forecast
- 9.1.1 Global Pulmonary Drug Delivery Devices/Systems Capacity, Production Forecast 2019-2025
- 9.1.2 Global Pulmonary Drug Delivery Devices/Systems Production Value Forecast 2019-2025
- 9.2 Market Forecast by Regions
- 9.2.1 Global Pulmonary Drug Delivery Devices/Systems Production and Value Forecast by Regions 2019-2025
- 9.2.2 Global Pulmonary Drug Delivery Devices/Systems Consumption Forecast by Regions 2019-2025
- 9.3 United States
- 9.3.1 Production and Value Forecast in United States
- 9.3.2 Consumption Forecast in United States
- 9.4 European Union
- 9.4.1 Production and Value Forecast in European Union
- 9.4.2 Consumption Forecast in European Union
- 9.5 China
- 9.5.1 Production and Value Forecast in China
- 9.5.2 Consumption Forecast in China
- 9.6 Rest of World
- 9.6.1 Japan
- 9.6.2 Korea
- 9.6.3 India
- 9.6.4 Southeast Asia
- 9.7 Forecast by Type
- 9.7.1 Global Pulmonary Drug Delivery Devices/Systems Production Forecast by Type
- 9.7.2 Global Pulmonary Drug Delivery Devices/Systems Production Value Forecast by Type
- 9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
- 10.1 Value Chain Analysis
- 10.2 Sales Channels Analysis
- 10.2.1 Pulmonary Drug Delivery Devices/Systems Sales Channels
- 10.2.2 Pulmonary Drug Delivery Devices/Systems Distributors
- 10.3 Pulmonary Drug Delivery Devices/Systems Customers
11 Opportunities & Challenges, Threat and Affecting Factors
- 11.1 Market Opportunities
- 11.2 Market Challenges
- 11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.1.1 Methodology/Research Approach
- 13.2 Author Details
Summary:
Get latest Market Research Reports on Pulmonary Drug Delivery Devices/Systems. Industry analysis & Market Report on Pulmonary Drug Delivery Devices/Systems is a syndicated market report, published as Global (United States, European Union and China) Pulmonary Drug Delivery Devices/Systems Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Pulmonary Drug Delivery Devices/Systems market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
